Birth Defects Spur FDA Plan to Limit Acne Drug
From Times Wire Reports
Government advisors want major new curbs in place on the use of the acne drug Accutane because it can cause severe birth defects.
Under the Food and Drug Administration plan, every male and female patient -- as well as health workers who prescribe Accutane and drugstores that dispense it -- would have to enroll in a national registry. The system would require that women get a pregnancy test before getting their monthly supply of Accutane.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
